Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype

21 Mar 2015

Abstract excerpt

BACKGROUND: Hemolytic disease of the fetus and newborn, classically caused by maternal-fetal incompatibility of the Rh blood group D antigen, can be prevented by RhIG prophylaxis. While prophylactic practices for pregnant women with serologic weak D phenotypes vary widely, RHD genotyping could provide clear guidance for management. This analysis evaluated the financial implications of using RHD genotyping to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood groups and transfusion
Share to Blood transfusion and management
Share to Neonatal Health and Biochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25808011
DOI: 10.1111/trf.13074

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotypePMID 25808011Read ↗

Relevance and costs of RHD genotyping in women with a weak D phenotype.Semantic proximity Read ↗

Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisSemantic proximity Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.Semantic proximity Read ↗

Resolving variable maternal D typing using serology and genotyping in selected prenatal patients.Semantic proximity Read ↗

Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.Semantic proximity Read ↗

Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American Pathologists.Semantic proximity Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.Semantic proximity Read ↗

Rh Immunoprophylaxis for Women With a Serologic Weak D Phenotype.Semantic proximity Read ↗

Fetal RHD genotyping is a cost-effective option for supporting targeted anti-D prophylaxis in D-negative pregnancies.Semantic proximity Read ↗

Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping.Semantic proximity Read ↗

RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.Semantic proximity Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.